Baxalta

RIXUBIS

Manufacturer:

Baxalta

Rixubis HCPCS:

J7200

HCPCS Code Descriptor:

Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu

Category:

J Code

Rixubis NDCs:

00944-3032-02, 00944-3026-02, 00944-3030-02, 00944-3028-02, 00944-3034-02

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Rixubis CPT Codes:

Potential CPT administration codes for Rixubis can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Rixubis:

RIXUBIS is a Hematology drug manufactured by Baxalta and administered via the Intravenous route of administration. The J Code: J7200 is aligned to the drug RIXUBIS.

ACCESS PRICING AND MORE BY REGISTERING

J7200 Added Date:

January 1, 2015

J7200 Effective Date:

January 1, 2015

J7200 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Rixubis billing and coding information.
Rixubis patient assistance information can be found through Takeda Patient Support at the URL: https://www.hematologysupport.com/financial-assistance#about-pap
RIXUBIS prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for RIXUBIS. Please check back in a few weeks.